Fermenta Biotech Limited (BOM:506414)
India
· Delayed Price · Currency is INR 338.10
+3.10 (0.93%)
At close: Jun 13, 2025
Fermenta Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 4,695 | 3,357 | 3,499 | 3,985 | 3,773 | Upgrade
|
| Revenue | 4,695 | 3,357 | 3,499 | 3,985 | 3,773 | Upgrade
|
Revenue Growth (YoY) | 39.87% | -4.08% | -12.19% | 5.63% | 28.79% | Upgrade
|
Cost of Revenue | 1,474 | 1,534 | 1,698 | 1,670 | 1,440 | Upgrade
|
Gross Profit | 3,221 | 1,822 | 1,801 | 2,315 | 2,333 | Upgrade
|
Selling, General & Admin | 651.04 | 620.8 | 618.6 | 660.6 | 605.53 | Upgrade
|
Other Operating Expenses | 1,472 | 923 | 1,003 | 1,039 | 909.04 | Upgrade
|
Operating Expenses | 2,365 | 1,791 | 1,904 | 1,955 | 1,718 | Upgrade
|
Operating Income | 855.81 | 31.17 | -103.27 | 359.77 | 615.15 | Upgrade
|
Interest Expense | -141.92 | -170.46 | -207.82 | -162.69 | -156.69 | Upgrade
|
Interest & Investment Income | - | 44.77 | 29.42 | 13.16 | 35.52 | Upgrade
|
Currency Exchange Gain (Loss) | - | 12.57 | 21.08 | 29.99 | 25.48 | Upgrade
|
Other Non Operating Income (Expenses) | 118.19 | 6.12 | 2.17 | 9.78 | -22.98 | Upgrade
|
EBT Excluding Unusual Items | 832.08 | -75.84 | -258.43 | 250.02 | 496.48 | Upgrade
|
Impairment of Goodwill | - | -74.26 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -0.59 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | -3.26 | -3.15 | -0.27 | -1.6 | Upgrade
|
Other Unusual Items | - | 54.09 | -251.6 | 12.81 | 21.42 | Upgrade
|
Pretax Income | 832.08 | -98.73 | -513.05 | 269.43 | 516.31 | Upgrade
|
Income Tax Expense | 68.05 | 141.36 | 18.27 | 118.83 | 91 | Upgrade
|
Earnings From Continuing Operations | 764.03 | -240.09 | -531.32 | 150.61 | 425.3 | Upgrade
|
Minority Interest in Earnings | 4.59 | 9.49 | 20.57 | 3.87 | 29.76 | Upgrade
|
Net Income | 768.62 | -230.6 | -510.75 | 154.47 | 455.07 | Upgrade
|
Net Income to Common | 768.62 | -230.6 | -510.75 | 154.47 | 455.07 | Upgrade
|
Net Income Growth | - | - | - | -66.05% | -23.55% | Upgrade
|
Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | Upgrade
|
Shares Outstanding (Diluted) | 29 | 29 | 29 | 29 | 29 | Upgrade
|
Shares Change (YoY) | 1.02% | 0.06% | -0.50% | -0.01% | 0.04% | Upgrade
|
EPS (Basic) | 26.35 | -7.99 | -17.70 | 5.35 | 15.77 | Upgrade
|
EPS (Diluted) | 26.35 | -7.99 | -17.70 | 5.33 | 15.69 | Upgrade
|
EPS Growth | - | - | - | -66.03% | -23.57% | Upgrade
|
Free Cash Flow | 187.69 | 861.39 | 756.19 | 63.13 | 73.26 | Upgrade
|
Free Cash Flow Per Share | 6.43 | 29.83 | 26.20 | 2.18 | 2.53 | Upgrade
|
Dividend Per Share | 2.500 | 1.250 | 1.250 | 1.250 | 2.500 | Upgrade
|
Dividend Growth | 100.00% | - | - | -50.00% | -50.00% | Upgrade
|
Gross Margin | 68.60% | 54.29% | 51.47% | 58.09% | 61.83% | Upgrade
|
Operating Margin | 18.23% | 0.93% | -2.95% | 9.03% | 16.30% | Upgrade
|
Profit Margin | 16.37% | -6.87% | -14.59% | 3.88% | 12.06% | Upgrade
|
Free Cash Flow Margin | 4.00% | 25.66% | 21.61% | 1.58% | 1.94% | Upgrade
|
EBITDA | 1,098 | 262.68 | 161.4 | 591.74 | 796.7 | Upgrade
|
EBITDA Margin | 23.39% | 7.83% | 4.61% | 14.85% | 21.12% | Upgrade
|
D&A For EBITDA | 242.18 | 231.52 | 264.67 | 231.96 | 181.55 | Upgrade
|
EBIT | 855.81 | 31.17 | -103.27 | 359.77 | 615.15 | Upgrade
|
EBIT Margin | 18.23% | 0.93% | -2.95% | 9.03% | 16.30% | Upgrade
|
Effective Tax Rate | 8.18% | - | - | 44.10% | 17.63% | Upgrade
|
Revenue as Reported | 4,813 | 3,475 | 3,585 | 4,067 | 3,855 | Upgrade
|
Advertising Expenses | - | 26.45 | 29.16 | 24.96 | 19.64 | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.